The biosimilar bevacizumab market is experiencing explosive growth, buoyed by rising global cancer rates and the urgent need for affordable oncology treatments. Bevacizumab, a monoclonal antibody marketed under the brand name Avastin, is a cornerstone of cancer therapy, inhibiting tumor blood vessel growth to slow progression in colorectal, lung, breast, and other cancers. As patents for the...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
